Research Article
Functional Reconstruction of Sarcoma Defects Utilising Innervated Free Flaps
Table 2
Outcome of the innervated flaps.
| Patient | Followup (months) | Complications | Muscle strength | DASH/LEFS | MSTS |
| 1 | 42 | Wound breakdown | M5 | 69 | 27 | 2 | 19 | — | M5 | 80 | 30 | 3 | Died of disease | — | — | — | — | 4 | (1) | Flap failure (necrosis at 1 month po), substituted with no innervated flap | — | — | — | 5 | 15 | Flap failure (necrosis at 5 days po), substituted with reinnervated lat. dorsi | M4 | 31(DASH) | 25 | 6 | 17 | Lymphoedema | M4 | 47 | 23 | 7 | 20 | Lymphoedema + superficial infection | M4 | 31 | 30 | 8 | 20 | — | M5 | 80 | 30 | 9 | 14 | — | M4 | 52 | 27 | 10 | 14 | — | M5 | 0 (DASH) | 30 | 11 | 15 | — | M4 | 14 (DASH) | 13 | 12 | 24 | Superficial infection at donor site | M5 | 57 | 30 | 13 | 24 | — | M5 | 78 | 30 | 14 | 18 | — | M5 | 73 | 26 | 15 | 6 | — | M4 | 75 | 27 | 16 | 6 | — | M5 | 80 | 30 | 17 | 8 | — | M4 | 80 | 30 | 18 | 8 | — | M4 | 65 | 26 | 19 | 12 | — | M3 | 65 | 25 | 20 | 18 | — | M5 | 80 | 30 | 21 | 20 | — | — | — | — | 22 | 23 | — | — | — | — |
|
|